Sector: Health Care
Director information for IQVIA HOLDINGS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Ari Bousbib | Chairman and CEO, IQVIA; Chairman and Chief Executive Officer | 64 | [] | [] | 2026 |
| Carol J. Burt | Principal, Burt-Hilliard Investments Senior Advisor, Consonance Capital Partners | 68 | ["Chair","Audit Committee Financial Expert"] | ["Audit","N&G","Audit Committee"] | 2026 |
| Colleen A. Goggins | Retired Member of Executive Committee and Worldwide Chair of Consumer Group, Johnson & Johnson; Chair of the Nominating and Governance Committee | 71 | ["Chair"] | ["LDC"] | 2026 |
| James A. Fasano | Retired Managing Director, CPP Investment Board; Chair | 56 | ["Chair","Audit Committee Financial Expert"] | ["N&G","Audit Committee"] | 2026 |
| John G. Danhakl | Managing Partner, Leonard Green & Partners, L.P. | 69 | [] | ["Audit","LDC"] | 2026 |
| John Leonard, M.D. | Lead Independent Director | ["Champions sustainability efforts","Engages with stockholders","Oversees sustainability matters"] | ["Nominating and Governance Committee"] | 2026 | |
| John M. Leonard, M.D. | President and Chief Executive Officer, Intellia Therapeutics, Inc. | 68 | ["Audit Committee Financial Expert"] | ["Audit","LDC","Audit Committee"] | 2026 |
| Leslie Wims Morris | Chief Executive Officer, Chase Auto, JP Morgan Chase | 55 | [] | ["Audit"] | 2026 |
| Ronald E. Bruehlman | Executive Vice President and Chief Financial Officer | 65 | [] | [] | 2026 |
| Sheila A. Stamps | Retired Managing Director, Bank of America | 68 | [] | ["Audit"] | 2026 |
| Todd B. Sisitsky | [] | [] | 2026 | ||
| William G. Kaelin Jr., M.D. | Senior Physician-Scientist, Brigham and Women’s Hospital Sidney Farber Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School | 68 | [] | [] | 2026 |
| W. Richard Staub, III | President, Research & Development Solutions | 63 | [] | [] | 2026 |
